SecProbe.io - Probe Score Transparency

Probe Score Transparency

Immix Biopharma, Inc. (IMMX)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence

Probe Score

1.5 / 10

Letters

1

Latest Activity

Jan. 16, 2026

Version

v1

Score Breakdown

Letter Count

1.0

Sentiment / Tone

0.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

0.0

Notable 8-K Count

0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
Jan. 16, 2026	CORRESP	Neutral/Informational	Moderate	Immix Biopharma, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on January 9, 2026. They ar…	Read Filing EDGAR
Jan. 16, 2026	UPLOAD	Neutral/Informational	Low	The SEC has communicated to Immix Biopharma, Inc. that it will not review their registration statement filed on January 9, 2026. The letter emphasizes that the responsibility for …	Read Filing EDGAR
Nov. 26, 2025	CORRESP	Neutral/Informational	Moderate	Immix Biopharma, Inc. has submitted a request to the SEC for the acceleration of their Form S-3 Registration Statement, seeking to have it become effective on December 1, 2025. Th…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.